A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Darat
A phase 1/2 trial of Sonrotoclax, Dexamethasone, Carfilzomib in multiple myeloma, run by BeOne Medicines, now recruiting.
Overview
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma is a phase 1/2 interventional study registered as NCT04973605 by BeOne Medicines, with 246 participants planned, started 2021-09-16 and due to reach its primary completion in 2026-11. Interventions recorded: Sonrotoclax, Dexamethasone, Carfilzomib, Daratumumab, Pomalidomide. Conditions listed: Relapsed/Refractory Multiple Myeloma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study of Daratumumab
Shares Carfilzomib, Pomalidomide, Daratumumab, Dexamethasone.
- TrialA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Rela
Shares Carfilzomib, Pomalidomide, Daratumumab, Dexamethasone.
- TrialA Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma
Shares Pomalidomide, Daratumumab, Dexamethasone, Multiple myeloma.
- TrialA Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)
Shares Pomalidomide, Daratumumab, Dexamethasone, Multiple myeloma.
- TrialA Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Shares Pomalidomide, Daratumumab, Dexamethasone, Multiple myeloma.
- TrialA Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination Wi
Shares Pomalidomide, Daratumumab, Dexamethasone, Multiple myeloma.
- TrialA Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With
Shares Carfilzomib, Pomalidomide, Dexamethasone, Multiple myeloma.
- TrialA Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Mult
Shares Carfilzomib, Pomalidomide, Dexamethasone, Multiple myeloma.